CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to develop advanced microbubbles for enhanced imaging and drug delivery in glioblastoma treatment. By engineering microbubbles for multimodal imaging, the project seeks to improve tumor resection and provide targeted therapy, paving the way for personalized cancer treatment.
Microbubbles (MBs) are used as contrast agent in ultrasound (US) imaging for a variety of tumours while little has been done for glioblastomas, a rare cancer.
Intraoperative Contrast-Enhanced US-imaging (CEUS) using lipidic MBs hold promises in increasing extent of resection of such tumors.
Furthermore, MBs gained recently interest as a delivery system for drugs.
We will develop a new generation of multimodal MBs, acting simultaneously as contrast agent for Magnetic Resonance Imaging (MRI), CEUS…
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Roma
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
SEROSCIENCE KFT SEROSCIENCERESEARCH DEVELOPMENT AND TRADE LTD
Hungary, Budapest
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Germany, DARMSTADT
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
